Warfarin-Related Intracerebral Hemorrhage: How to Proceed

• Hart RG , TonarelliSB, PearceLA: Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas.Stroke36, 1588–1593(2005).
   PubMed Web of Science ®Google Scholar
• Gage BF , MilliganPE: Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.Thrombosis Res.117, 55–59; discussion 65–67 (2005).
   Google Scholar
• Flaherty ML , KisselaB, WooDet al.: The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology68, 116–121(2007).
   PubMed Web of Science ®Google Scholar
• Aguilar MI , HartRG, KaseCSet al.: Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin. Proc.82, 82–92(2007).
   PubMed Web of Science ®Google Scholar
• Falk RH : Atrial fibrillation. (Erratum appears inN. Engl. J. Med.344(24), 1876 [2001]) N. Engl. J. Med.344, 1067–1078(2001).
   Google Scholar
• Hart RG , AguilarMI: Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage.J. Thromb. Thrombolysis25, 26–32(2007).
   PubMed Web of Science ®Google Scholar
• Aguilar MI , HartRG, PearceLA: Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.Cochrane Database of Syst. Rev. (2008) (Epub ahead of print).
   Google Scholar
• The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N. Engl. J. Med.323, 1505–1511(1990).
   PubMed Web of Science ®Google Scholar
• European Atrial Fibrillation Trial (EAFT) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet342, 1255–1262(1993).
   PubMed Web of Science ®Google Scholar
• Fang MC , StaffordRS, RuskinJN, SingerDE: National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.Arch. Intern. Med.164, 55–60(2004).
   PubMed Web of Science ®Google Scholar
• Hart RG , HalperinJL, PearceLAet al.: Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med.138, 831–838(2003).
   PubMed Web of Science ®Google Scholar
• Hart RG , PearceLA, AguilarMI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.Ann. Intern. Med.146, 857–867(2007).
   PubMed Web of Science ®Google Scholar
• Smith NL , PsatyBM, FurbergCDet al.: Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch. Intern. Med.159, 1574–1578(1999).
   PubMedGoogle Scholar
• The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann. Neurol.42, 857–865(1997).
   PubMed Web of Science ®Google Scholar
• Hylek EM , Evans-MolinaC, SheaC, HenaultLE, ReganS: Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.Circulation115, 2689–2696(2007).
   PubMed Web of Science ®Google Scholar
• Hylek EM , GoAS, ChangYet al.: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N. Engl. J. Med.349, 1019–1026(2003).
   PubMed Web of Science ®Google Scholar
• Fang MC , ChangY, HylekEMet al.: Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann. Intern. Med.141, 745–752(2004).
   PubMed Web of Science ®Google Scholar
• Gage BF : Pharmacogenetics-based coumarin therapy.Hematology467–473(2006).
   PubMedGoogle Scholar
• Gage BF , EbyC, MilliganPE, BanetGA, DuncanJR, McLeodHL: Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.Thromb. Haemost.91, 87–94(2004).
   PubMed Web of Science ®Google Scholar
• Berwaerts J , RobbOJ, JeffersTA, WebsterJ: Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Scott. Med. J.45, 101–104(2000).
   PubMed Web of Science ®Google Scholar
• Sjoblom L , HardemarkHG, LindgrenAet al.: Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke32, 2567–2574(2001).
   PubMed Web of Science ®Google Scholar
• Yasaka M , OomuraM, IkenoK, Naritomi H, Minematsu K: Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose. Ann. Hematol.82, 121–123(2003).
   PubMed Web of Science ®Google Scholar
• Flibotte JJ , HaganN, O‘DonnellJ, GreenbergSM, RosandJ: Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.Neurology63, 1059–1064(2004).
   PubMed Web of Science ®Google Scholar
• Yasaka M , MinematsuK, NaritomiH, SakataT, YamaguchiT: Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin.Thromb. Haemost.89, 278–83(2003).
   PubMed Web of Science ®Google Scholar
• Ichikawa K , YanagiharaC: Sedimentation level in acute intracerebral hematoma in a patient receiving anticoagulation therapy: an autopsy study.Neuroradiology40, 380–382(1998).
   PubMed Web of Science ®Google Scholar
• Hart RG , BoopBS, AndersonDC: Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.Stroke26, 1471–1477(1995).
   PubMed Web of Science ®Google Scholar
• Laissy JP , NormandG, MonrocM, DuchateauC, AlibertF, ThiebotJ: Spontaneous intracerebral hematomas from vascular causes. Predictive value of CT compared with angiography.Neuroradiology33, 291–295(1991).
   PubMed Web of Science ®Google Scholar
• Flaherty ML , HaverbuschM, SekarPet al.: Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit. Care5, 197–201(2006).
   PubMed Web of Science ®Google Scholar
• Fihn SD , CallahanCM, MartinDC, McDonellMB, HenikoffJG, WhiteRH: The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.Ann. Intern. Med.124, 970–979(1996).
   PubMed Web of Science ®Google Scholar
• Hylek EM , SingerDE: Risk factors for intracranial hemorrhage in outpatients taking warfarin.Ann. Intern. Med.120, 897–902(1994).
   PubMed Web of Science ®Google Scholar
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet343, 687–691(1994).
   PubMed Web of Science ®Google Scholar
• van der Meer FJ , RosendaalFR, VandenbrouckeJP, BrietE: Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.Arch. Intern. Med.153, 1557–1562(1993).
   PubMed Web of Science ®Google Scholar
• Lackie CL , GarbarinoKA, PruetzJA: Warfarin therapy for atrial fibrillation in the elderly.Ann. Pharmacother.36, 200–204(2002).
   PubMed Web of Science ®Google Scholar
• Hylek EM , ReganS, GoAS, HughesRA, SingerDE, SkatesSJ: Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.Ann. Intern. Med.135, 393–400(2001).
   PubMed Web of Science ®Google Scholar
• Demchuk AM , MorgensternLB, Krieger DW et al.: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke30, 34–39(1999).
   PubMed Web of Science ®Google Scholar
• Berwaerts J , WebsterJ: Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages.QJM93, 513–521(2000).
   PubMedGoogle Scholar
• Smith EE , RosandJ, KnudsenKA, Hylek EM, Greenberg SM: Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology59, 193–197(2002).
   PubMed Web of Science ®Google Scholar
• Gorter JW : Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention in Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.Neurology53, 1319–1327(1999).
   PubMed Web of Science ®Google Scholar
• Diener HC , BogousslavskyJ, BrassLMet al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet364, 331–537(2004).
   PubMed Web of Science ®Google Scholar
• Fazekas F , KleinertR, RoobGet al.: Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am. J. Neuroradiol.20, 637–642(1999).
   PubMed Web of Science ®Google Scholar
• Roob G , LechnerA, SchmidtR, FloohE, HartungHP, FazekasF: Frequency and location of microbleeds in patients with primary intracerebral hemorrhage.Stroke31, 2665–2659(2000).
   PubMed Web of Science ®Google Scholar
• Roob G , SchmidtR, KapellerP, LechnerA, HartungHP, FazekasF: MRI evidence of past cerebral microbleeds in a healthy elderly population.Neurology52, 991–994(1999).
   PubMed Web of Science ®Google Scholar
• Derex L , HermierM, AdeleinePet al.: Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J. Neurol. Neurosurg. Psychiatr.76, 70–75(2005).
   PubMed Web of Science ®Google Scholar
• Derex L , NighoghossianN, HermierMet al.: Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc. Dis.17, 238–241(2004).
   PubMed Web of Science ®Google Scholar
• Ferro JM : Update on intracerebral haemorrhage.J. Neurol.253, 985–999(2006).
   PubMed Web of Science ®Google Scholar
• Greenberg SM , EngJA, NingM, SmithEE, RosandJ: Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage.Stroke35, 1415–1420(2004).
   PubMed Web of Science ®Google Scholar
• Rosand J , HylekEM, O‘DonnellHC, GreenbergSM: Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.Neurology55, 947–951(2000).
   PubMed Web of Science ®Google Scholar
• Hylek EM , SkatesSJ, SheehanMA, Singer DE: An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N. Engl. J. Med.335, 540–546(1996).
   PubMed Web of Science ®Google Scholar
• Broderick J , ConnollyS, FeldmannEet al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke38, 2001–2023(2007).
   PubMed Web of Science ®Google Scholar
• Diringer MN , EdwardsDF: Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage.Crit. Care Med.29, 635–640(2001).
   PubMed Web of Science ®Google Scholar
• Hemphill JC 3rd, Bleck T, Carhuapoma JR et al.: Is neurointensive care really optional for comprehensive stroke care? Stroke36, 2344–2345(2005).
   PubMedGoogle Scholar
• Mirski MA , ChangCW, CowanR: Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care.J. Neurosurg. Anesthesiol.13, 83–92(2001).
   PubMed Web of Science ®Google Scholar
• Suarez JI , ZaidatOO, SuriMFet al.: Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit. Care Med.32, 2311–2317(2004).
   PubMed Web of Science ®Google Scholar
• Sung GY : Outcomes of neurocritical care.Curr. Neurol. Neurosci. Rep.1, 593–598(2001).
   PubMedGoogle Scholar
• Varelas PN , SpanakiMV, Hacein-BeyL: Documentation in medical records improves after a neurointensivist‘s appointment.Neurocrit. Care3, 234–236(2005).
   PubMed Web of Science ®Google Scholar
• Goldstein JN , FazenLE, SniderRet al.: Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology68, 889–894(2007).
   PubMed Web of Science ®Google Scholar
• Ardelt AA , ArenbergS, KuleszaP, Streiff MB: Anticoagulation in patients with intracerebral hemorrhage; a survey of Neurocritical Case society members. 4th Annual Meeting Neurocritical Care Society, Baltimore, MD, USA, 4–5 November 2006, 240 (2007).
   Google Scholar
• Hirsh J , FusterV, AnsellJ, Halperin JL; American Heart Association/American College of Cardiology: American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J. Am. Coll. Cardiol.41, 1633–1652(2003).
   PubMed Web of Science ®Google Scholar
• Micromedex. Physician‘s Desk Reference. (2001).
   Google Scholar
• Steiner T , RosandJ, DiringerM: Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions.Stroke37, 256–262(2006).
   PubMed Web of Science ®Google Scholar
• Riegert-Johnson DL , VolcheckGW: The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review.Ann. Allergy Asthma Immunol.89, 400–406(2002).
   PubMed Web of Science ®Google Scholar
• Goldstein JN , ThomasSH, FrontieroVet al.: Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke37, 151–155(2006).
   PubMed Web of Science ®Google Scholar
• Lee SB , MannoEM, LaytonKF, Wijdicks EF: Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology67, 1272–1274(2006).
   PubMed Web of Science ®Google Scholar
• Boulis NM , BobekMP, SchmaierA, Hoff JT: Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery45, 1113–1118; discussion 1118–1119 (1999).
   PubMed Web of Science ®Google Scholar
• Brody DL , AiyagariV, ShacklefordAM, DiringerMN: Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.Neurocrit. Care2, 263–267(2005).
   PubMed Web of Science ®Google Scholar
• Makris M , GreavesM, PhillipsWS, Kitchen S, Rosendaal FR, Preston EF: Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb. Haemost.77, 477–80(1997).
   PubMed Web of Science ®Google Scholar
• Schulman S : Clinical practice. Care of patients receiving long-term anticoagulant therapy.N. Engl. J. Med.349, 675–683(2003).
   PubMed Web of Science ®Google Scholar
• Fredriksson K , NorrvingB, StrombladLG: Emergency reversal of anticoagulation after intracerebral hemorrhage.Stroke23, 972–977(1992).
   PubMed Web of Science ®Google Scholar
• Yasaka M , SakataT, MinematsuK, Naritomi H: Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb. Res.108, 25–30(2002).
   PubMed Web of Science ®Google Scholar
• Ansell J , HirshJ, PollerL, BusseyH, Jacobson A, Hylek E: The pharmacology and management of the vitamin antagonists K: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (Erratum appears in Chest127(1), 415–416)Chest126, 204S–233S (2004).
   Web of Science ®Google Scholar
• Cartmill M , DolanG, ByrneJL, ByrnePO: Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies.Br. J. Neurosurg.14, 458–461(2000).
   PubMed Web of Science ®Google Scholar
• Preston FE , LaidlawST, SampsonB, KitchenS: Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients.Br. J. Haematol.116, 619–624(2002).
   PubMed Web of Science ®Google Scholar
• British Society for Haematology: Haematology: guidelines on oral anticoagulation: second edition. J. Clin. Pathol.177–183(1990).
   PubMed Web of Science ®Google Scholar
• Hellstern P , HalbmayerWM, KohlerM, SeitzR, Muller-BerghausG: Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary.Thromb. Res.95, S3–S6 (1999).
   PubMed Web of Science ®Google Scholar
• Chowdhury P , SaaymanAG, PaulusU, FindlayGP, CollinsPW: Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.Br. J. Haematol.125, 69–73(2004).
   PubMed Web of Science ®Google Scholar
• Kohler M : Thrombogenicity of prothrombin complex concentrates.Thromb. Res.95, S13–S17 (1999).
   PubMed Web of Science ®Google Scholar
• Mayer SA , BrunNC, BegtrupKet al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med.352, 777–85(2005).
   PubMed Web of Science ®Google Scholar
• Mayer SA ; FAST Trial Steering Committee: Complications in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology69, 319–320(2007).
   PubMed Web of Science ®Google Scholar
• Freeman WD , BrottTG, BarrettKMet al.: Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin. Proc.79, 1495–500(2004).
   PubMed Web of Science ®Google Scholar
• Sorensen B , JohansenP, NielsenGL, SorensenJC, IngerslevJ: Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.Blood Coagul. Fibrinolysis14, 469–477(2003).
   PubMed Web of Science ®Google Scholar
• Veshchev I , ElranH, SalameK: Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma.Med. Sci. Monit.8, CS98–CS100 (2002).
   PubMedGoogle Scholar
• Kohler M , HeidenM, HarbauerGet al.: Comparison of different prothrombin complex concentrates – in vitro and in vivo studies. Thromb. Res.60, 63–70(1990).
   PubMed Web of Science ®Google Scholar
• Levi M , BijsterveldNR, KellerTT: Recombinant factor VIIa as an antidote for anticoagulant treatment.Semin. Hematol.41, 65–69(2004).
   PubMed Web of Science ®Google Scholar
• Makris M , WatsonH: Reversal of coumarin-induced over-anticoagulation.Br. J. Haematol.926 (2002).
   PubMed Web of Science ®Google Scholar
• Mendelow AD , GregsonBA, Fernandes HM et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet365, 387–397(2005).
   PubMed Web of Science ®Google Scholar
• Freeman WD , CalvoP, AduenJF, OhannessianJ, DarracottRM, Rabisntein AA: Factor VIIa for rapid warfarin anticoagulation reversal in acute intracranial hemorrhage in 46 patients. Neurocrit. Care220 (2007).
   Google Scholar
• Rabinstein AA , WijdicksEF: Surgery for intracerebral hematoma: the search for the elusive right candidate.Rev. Neurol. Dis.3, 163–172(2006).
   PubMedGoogle Scholar
• Rabinstein AA , WijdicksEF: Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation.Arch. Neurol.64, 203–206(2007).
   PubMedGoogle Scholar
• Rosand J , EckmanMH, KnudsenKA, SingerDE, GreenbergSM: The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.Arch. Intern. Med.164, 880–884(2004).
   PubMed Web of Science ®Google Scholar
• Radberg JA , OlssonJE, RadbergCT: Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment.Stroke22, 571–576(1991).
   PubMed Web of Science ®Google Scholar
• Neau JP , CouderqC, IngrandP, BlanchonP, GilR: Intracranial hemorrhage and oral anticoagulant treatment.Cerebrovasc. Dis.11, 195–200(2001).
   PubMed Web of Science ®Google Scholar
• Bertram M , BonsantoM, HackeW, Schwab S: Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J. Neurol.247, 209–214(2000).
   PubMed Web of Science ®Google Scholar
• Crawley F , BevanD, WrenD: Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valves.J. Neurol. Neurosurg. Psychiatr.69, 396–398(2000).
   PubMed Web of Science ®Google Scholar
• Leker RR , AbramskyO: Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma.Neurology50, 1489–1491(1998).
   PubMed Web of Science ®Google Scholar
• Phan TG , KohM, WijdicksEF: Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk.Arch. Neurol.57, 1710–1713(2000).
   PubMedGoogle Scholar
• Punthakee X , DoobayJ, AnandSS: Oral-anticoagulant-related intracerebral hemorrhage.Thromb. Res.108, 31–36(2002).
   PubMed Web of Science ®Google Scholar
• Wijdicks EF , SchievinkWI, BrownRD, MullanyCJ: The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves.Neurosurgery42, 769–773(1998).
   PubMed Web of Science ®Google Scholar
• Eckman MH , RosandJ, KnudsenKA, Singer DE, Greenberg SM: Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke34, 1710–1716(2003).
   PubMed Web of Science ®Google Scholar
• Newell CA , AndersonLA, PhillipsonJD: Herbal Medicines: a Guide to Health Care Professionals. The Pharmaceutical Press, London, UK 282 (1996).
   Google Scholar

Websites

• The Internet Stroke Center: the stroke trials registry. www.stroketrials.gov
   Google Scholar
• Clinical Trials Networks Best Practices: NIH Roadmap. www.ctnbestpractices.org/bpforum/trials-recruiting-sites/rocket-af
   Google Scholar
• Evidence based, peer reviewed information resource. www.uptodate.com
   Google Scholar